Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.

This is the first study to demonstrate the real-world effectiveness and safety of enzalutamide in men with nmCRPC in Japan, further informing healthcare providers about available treatment options for this patient population.